We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
2651
DELISTED
KalVista Pharmaceuticals
KALV
| $403K | ﹤0.01% |
41,895
+164
| +0.4% | +$1.68K |
|
2652
West Bancorporation
WTBA
$485M
| $403K | ﹤0.01% |
24,708
+83
| +0.3% | +$1.53K |
|
2653
Atea Pharmaceuticals
AVIR
$420M
| $403K | ﹤0.01% |
134,308
-6,747
| -5% | -$23K |
|
2654
GSK
GSK
$106B
| $402K | ﹤0.01% |
11,100
+555
| +5% | +$19.7K |
|
|
SCU
2655
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $402K | ﹤0.01% |
34,636
-1,531
| -4% | -$16.8K |
|
2656
Citizens & Northern Corp
CZNC
$455M
| $401K | ﹤0.01% |
22,869
-19
| -0.1% | -$368 |
|
|
TBRG
2657
DELISTED
TruBridge
TBRG
| $399K | ﹤0.01% |
25,054
-23,408
| -48% | -$477K |
|
2658
FTAI Infrastructure
FIP
$505M
| $398K | ﹤0.01% |
123,498
+5,068
| +4% | +$17.5K |
|
2659
Utah Medical Products
UTMD
$225M
| $398K | ﹤0.01% |
4,623
+124
| +3% | +$11.4K |
|
2660
Babcock & Wilcox
BW
$1.39B
| $398K | ﹤0.01% |
94,425
+1,504
| +2% | +$7.85K |
|
|
EBTC
2661
DELISTED
Enterprise Bancorp
EBTC
| $397K | ﹤0.01% |
14,508
-219
| -1% | -$6.41K |
|
2662
Lyell Immunopharma
LYEL
$360M
| $395K | ﹤0.01% |
13,441
-304
| -2% | -$14.4K |
|
2663
Riley Exploration Permian
REPX
$758M
| $393K | ﹤0.01% |
12,378
+88
| +0.7% | +$2.99K |
|
2664
8x8 Inc
EGHT
$332M
| $393K | ﹤0.01% |
156,114
-191,345
| -55% | -$680K |
|
2665
Sierra Bancorp
BSRR
$525M
| $393K | ﹤0.01% |
20,712
-57
| -0.3% | -$1.12K |
|
2666
Cosan
CSAN
$2.84B
| $392K | ﹤0.01% |
28,857
+2,380
| +9% | +$36.3K |
|
|
BAND
2667
Bandwidth Inc
BAND
$1.61B
| $391K | ﹤0.01% |
34,710
-26,104
| -43% | -$356K |
|
2668
Holley
HLLY
$384M
| $391K | ﹤0.01% |
78,288
+1,365
| +2% | +$7.73K |
|
2669
ACNB Corp
ACNB
$655M
| $389K | ﹤0.01% |
12,297
-51
| -0.4% | -$1.69K |
|
|
MITSY
2670
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
| $389K | ﹤0.01% |
535
+27
| +5% | +$19.6K |
|
2671
ThredUp
TDUP
$422M
| $388K | ﹤0.01% |
96,641
+3,298
| +4% | +$11.2K |
|
|
VTNR
2672
DELISTED
Vertex Energy, Inc
VTNR
| $386K | ﹤0.01% |
86,849
-170
| -0.2% | -$873 |
|
2673
Waldencast
WALD
$178M
| $386K | ﹤0.01% |
41,003
+21,108
| +106% | +$150K |
|
2674
NextNav
NN
$2.23B
| $385K | ﹤0.01% |
74,965
-119,584
| -61% | -$482K |
|
2675
ProFrac Holding
ACDC
$787M
| $385K | ﹤0.01% |
35,384
+1,602
| +5% | +$18.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.